SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001607062-15-000273
Filing Date
2015-06-25
Accepted
2015-06-25 15:50:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 PRER14A gnbt60215sch14a.htm PRER14A 571457
  Complete submission text file 0001607062-15-000273.txt   572457
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: PRER14A | Act: 34 | File No.: 000-25169 | Film No.: 15951782
SIC: 2834 Pharmaceutical Preparations